OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
OneMedNet (Nasdaq: ONMD), a leading curator of regulatory-grade Real World Data (RWD), has announced a strategic refresh of its Board of Directors following its successful transition to a publicly traded entity. The company has welcomed two new board members: Jair Clarke, an Executive Advisor at World Wide Technology and CEO of Laigic, and Sherry Coonse McCraw, VP of Human Resources and former CFO of BMW North America.
Clarke's experience in AI, digital intelligence, and technology strategy is expected to contribute to market expansion, technology platform enhancement, and operational efficiency. McCraw, as the new head of the audit committee, will focus on financial oversight, transparency, and human resources leadership. This transition aims to enhance corporate governance and leverage diverse expertise to guide OneMedNet through its next growth phase.
OneMedNet (Nasdaq: ONMD), un curatore leader di dati reali di grado regolatorio (RWD), ha annunciato un rinnovamento strategico del suo Consiglio di Amministrazione in seguito alla sua riuscita transizione a ente quotato in borsa. L'azienda ha accolto due nuovi membri del consiglio: Jair Clarke, un consulente esecutivo presso World Wide Technology e CEO di Laigic, e Sherry Coonse McCraw, VP delle Risorse Umane e ex CFO di BMW Nord America.
Si prevede che l'esperienza di Clarke in intelligenza artificiale, intelligenza digitale e strategia tecnologica contribuisca all'espansione del mercato, al miglioramento della piattaforma tecnologica e all'efficienza operativa. McCraw, in qualità di nuova responsabile del comitato di audit, si concentrerà sulla supervisione finanziaria, la trasparenza e la leadership delle risorse umane. Questa transizione mira a potenziare la governance aziendale e sfruttare competenze diversificate per guidare OneMedNet nella sua prossima fase di crescita.
OneMedNet (Nasdaq: ONMD), un curador líder de datos del mundo real de grado regulatorio (RWD), ha anunciado una renovación estratégica de su Junta Directiva tras su exitosa transición a entidad cotizada en bolsa. La compañía ha recibido a dos nuevos miembros en la junta: Jair Clarke, asesor ejecutivo en World Wide Technology y CEO de Laigic, y Sherry Coonse McCraw, VP de Recursos Humanos y ex CFO de BMW Norteamérica.
Se espera que la experiencia de Clarke en IA, inteligencia digital y estrategia tecnológica contribuya a la expansión del mercado, la mejora de la plataforma tecnológica y la eficiencia operativa. McCraw, como nueva cabeza del comité de auditoría, se centrará en la supervisión financiera, la transparencia y el liderazgo en recursos humanos. Esta transición tiene como objetivo mejorar la gobernanza corporativa y aprovechar la experiencia diversa para guiar a OneMedNet en su próxima fase de crecimiento.
OneMedNet (Nasdaq: ONMD), 규제 기준의 실제 데이터(RWD)의 주요 큐레이터,는 상장 기업으로 성공적으로 전환한 후 이사회를 전략적으로 개편한다고 발표했습니다. 회사는 두 명의 새로운 이사회를 환영했습니다: Jair Clarke, 월드와이드 테크놀로지의 전무 고문이자 Laigic의 CEO, 그리고 Sherry Coonse McCraw, 북미 BMW의 전 CFO이자 인사 부사장입니다.
Clarke의 AI, 디지털 지능 및 기술 전략에 대한 경험은 시장 확대, 기술 플랫폼 개선 및 운영 효율성에 기여할 것으로 예상됩니다. McCraw은 감사 위원회의 새로운 책임자로서 재무 감독, 투명성 및 인사 리더십에 집중할 것입니다. 이번 전환은 기업 거버넌스를 강화하고 다양한 전문지식을 활용하여 OneMedNet이 다음 성장 단계로 나아가도록 안내하는 것을 목표로 합니다.
OneMedNet (Nasdaq: ONMD), un leader dans la curation de données réelles conformes (RWD), a annoncé un renouvellement stratégique de son Conseil d'Administration suite à sa transition réussie en tant qu'entité cotée en bourse. La société a accueilli deux nouveaux membres au conseil : Jair Clarke, conseiller exécutif chez World Wide Technology et CEO de Laigic, et Sherry Coonse McCraw, VP des Ressources Humaines et ancienne CFO de BMW Amérique du Nord.
L'expérience de Clarke en IA, intelligence numérique et stratégie technologique devrait contribuer à l'expansion du marché, à l'amélioration de la plateforme technologique et à l'efficacité opérationnelle. McCraw, en tant que nouvelle responsable du comité d'audit, se concentrera sur la supervision financière, la transparence et le leadership en ressources humaines. Cette transition vise à améliorer la gouvernance d'entreprise et à tirer parti d'une expertise diversifiée pour guider OneMedNet dans sa prochaine phase de croissance.
OneMedNet (Nasdaq: ONMD), ein führender Anbieter von regulatorischen Real-World-Daten (RWD), hat eine strategische Erneuerung seines Vorstands nach dem erfolgreichen Übergang zu einem börsennotierten Unternehmen angekündigt. Das Unternehmen hat zwei neue Vorstandsmitglieder begrüßt: Jair Clarke, ein exekutiver Berater bei World Wide Technology und CEO von Laigic, sowie Sherry Coonse McCraw, VP für Personalwesen und ehemalige CFO von BMW Nordamerika.
Clarks Erfahrung in KI, digitaler Intelligenz und Technologie-Strategie wird voraussichtlich zur Markterweiterung, Verbesserung der Technologieplattform und Betriebseffizienz beitragen. McCraw wird als neue Leiterin des Prüfungsausschusses den Fokus auf finanzielle Überwachung, Transparenz und Führungsstärke im Personalwesen legen. Dieser Übergang zielt darauf ab, die Unternehmensführung zu verbessern und vielfältige Expertise zu nutzen, um OneMedNet durch seine nächste Wachstumsphase zu leiten.
- Successful transition to a publicly traded entity (IPO completed)
- Strategic refresh of Board of Directors with experienced new members
- New board members bring expertise in AI, digital intelligence, and financial oversight
- Focus on market expansion, technology enhancement, and operational efficiency
- None.
MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This move reinforces our commitment to dynamic leadership and active engagement as we accelerate growth in this new phase.
We extend our heartfelt gratitude to Paul Casey, and Erkan Akyuz for their invaluable contributions during a pivotal time in our company's history. Their leadership and guidance were instrumental in achieving our IPO, laying a strong foundation as OneMedNet entered the public markets. We thank them for their service and wish them the best in their future endeavors.
In alignment with our vision for the future, we are excited to welcome two distinguished individuals to our Board.
Jair Clarke, currently serves as Executive Advisor to the Chairman at World Wide Technology (WWT), holds the position of CEO at Laigic and is a board member of Xponential (NYSE:XPOF) that is focused on health and wellness. His career also includes a tenure as a Global CTO at Microsoft, where he was pivotal in shaping the company's technological direction. Prior to this, he led Disney’s Big Data, technology strategy and digital intelligence and co-led IBM Watson’s strategy and delivery.
Jair’s experience positions him to contribute to the following business priorities:
- Market Expansion and Business Development: Leveraging his extensive network and insights in AI and digital intelligence to explore new markets and forge strategic partnerships.
- Technology Platform Enhancement: Bringing his expertise from Microsoft, Disney and IBM Watson to refine OneMedNet technology solutions.
- Operational Efficiency: Focusing on greater effectiveness and scalability.
Sherry Coonse McCraw, currently the VP of Human Resources and former CFO of BMW North America, brings a diverse background in both finance and human capital strategy. As the new head of our audit committee, her expertise will be critical in:
- Financial Oversight: Ensuring robust financial governance and strategic planning.
- Transparency and Accountability: Maintaining integrity and trust as we scale our operations.
- Human Resources Leadership: Combining her HR and financial experience to align human capital strategies with organizational goals.
"OneMedNet is at an exciting juncture, and the addition of Sherry and Jair to our Board is a testament to our commitment to excellence and innovation," said Jeffrey Yu, MD, Founder and Chairman of OneMedNet. “We are grateful for the foundational work of Paul and Erkan, and with Sherry and Jair onboard, we are well-positioned to drive our company towards new heights.”
This transition reflects our strategic focus on enhancing corporate governance, leveraging diverse expertise, and ensuring that our Board is equipped to guide OneMedNet through its next phase of growth and innovation.
About OneMedNet Corporation
OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet’s proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers.
OneMedNet’s platform is designed to meet the clinical requirements necessary across various domains, including but not limited to rare diseases, oncology, and cardiology. The Company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information, please visit www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Michael Wong, Director of Marketing
Phone: 800.918.7189
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
Who are the new board members joining OneMedNet (ONMD)?
What expertise do the new OneMedNet (ONMD) board members bring?
What are the main goals of OneMedNet's (ONMD) board refresh?
How does OneMedNet (ONMD) plan to use the new board members' expertise?
